Comments on: U.S. Food & Drug Administration Grants Priority Review of Maribavir for the Treatment of Post-Transplant Recipients With Cytomegalovirus Infection in Those Resistant and/or Refractory to Prior Anti-CMV Treat

Comments on: U.S. Food & Drug Administration Grants Priority Review of Maribavir for the Treatment of Post-Transplant Recipients With Cytomegalovirus Infection in Those Resistant and/or Refractory to Prior Anti-CMV Treat http://mavericktimes.in/news/agency-copies/u-s-food-drug-administration-grants-priority-review-of-maribavir-for-the-treatment-of-post-transplant-recipients-with-cytomegalovirus-infection-in-those-resistant-and-or-refractory-to-prior-ant/11271/ News Content Website Sat, 22 May 2021 13:48:53 +0000 hourly 1